{"id":"NCT01297959","sponsor":"Excited States, LLC","briefTitle":"Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery","officialTitle":"Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study --Inhibition of Incisional Infections)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01-10","primaryCompletion":"2015-10-14","completion":"2015-10-14","firstPosted":"2011-02-17","resultsPosted":"2021-01-19","lastUpdate":"2021-02-10"},"enrollment":503,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Infections"],"interventions":[{"type":"DRUG","name":"E-101 Solution 300 GU/ml","otherNames":[]},{"type":"DRUG","name":"Saline solution","otherNames":[]}],"arms":[{"label":"E-101 Solution 300 GU/mL","type":"EXPERIMENTAL"},{"label":"Placebo (Saline solution)","type":"PLACEBO_COMPARATOR"}],"summary":"This study is intended to determine the efficacy, safety and tolerability of topical application of E-101 Solution directly into the surgical incisional wound in the prevention of infection of superficial and deep surgical incisional wounds. E-101 Solution is an enzyme-based antiseptic that is being developed for direct application to a surgical incision.","primaryOutcome":{"measure":"Number of Participants In Intent to Treat (ITT) Analysis Set With Superficial and Deep Incisional Surgical Site Infections (SSI) Involving Principal Incision Within 30 Days After Index-surgery as Determined by Blinded Assessors 30 Days Post-operatively","timeFrame":"Surgery (Day 0) up to 30 days post-surgery","effectByArm":[{"arm":"E-101 Solution 300 GU/mL","deltaMin":53,"sd":null},{"arm":"Placebo (Saline Solution)","deltaMin":41,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.39"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":39,"countries":["United States","Israel"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":57,"n":248},"commonTop":["Nausea","Vomiting","Pyrexia","Hypokalaemia","Tachycardia"]}}